Department of Pharmaceutics and Center of Excellence for Pharmaceutical Translational Research and Education, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey
Sijia Yu is a Research Investigator at Bristol Myers Squibb, specializing in pharmacometrics. With an impressive educational background, Sijia holds a Ph.D. in Pharmaceutical Science from Rutgers University and dual master's degrees in Computer Science and Biomedical Science from Temple University. Her academic journey began with a B.S. in Biotechnology from China Pharmaceutical University.
Professionally, Sijia has contributed to the development of compounds across various therapeutic areas, particularly in pharmacokinetic modeling and simulation, since joining the company in October 2024. Her PhD research was focused on developing PBPK models for apixaban to understand potential tissue toxicities, establishing PBPK/QSP models for trastuzumab-induced cardiotoxicity, and utilizing popPK models for rifampin dose optimization in pediatric patients. Prior to her current position, Sijia acquired invaluable experience through summer internships at Bristol Myers Squibb and Genentech. Throughout these internships, she actively engaged in PK/PD and PBPK/PD modeling and simulation to support dose projection.